title: A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening.
abstract: Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost-effectiveness of these new technologies must be established in properly designed trials before they can be implemented within national public health programs. Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test.
authors.affiliation: European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France. philip.davies@ecca.fr
authors.forename: Philip
authors.initials: P
authors.lastname: Davies
authors.forename: Marc
authors.initials: M
authors.lastname: Arbyn
authors.forename: Joakim
authors.initials: J
authors.lastname: Dillner
authors.forename: Henry C
authors.initials: HC
authors.lastname: Kitchener
authors.forename: Chris J L M
authors.initials: CJ
authors.lastname: Meijer
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Ronco
authors.forename: Matti
authors.initials: M
authors.lastname: Hakama
mesh_terms: D004279:DNA, Viral / Q000032:analysis; D005060:Europe; D005260:Female; D006801:Humans; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000150:complications* / Q000175:diagnosis*; D011634:Public Health; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000821:virology*
chemical_list: D004279:DNA, Viral